This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
6 Multiline Insurers to Watch Out for Amid Operational Challenges
by Tanuka De
Better pricing, product redesigns and increased adoption of technology are expected to aid multiline insurers like CI, MET, CNO, HMN, ORI, and MTG. However, a low-rate environment remains a headwind.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Allstate Announces Transformative Growth Plan, To Incur Costs
by Zacks Equity Research
Business-transformation charges and low interest rates are likely to drag Allstate's (ALL) underwriting margins.
Here's Why You Should Retain MetLife Stock in Your Portfolio
by Zacks Equity Research
MetLife (MET) is poised for growth, given its enhanced benefit solutions, cost-control efforts and sound solvency position.
MetLife Boosts Group Benefits Business With Acquisition
by Zacks Equity Research
MetLife (MET) inks an all-cash deal to acquire Versant Health, which is intended to enhance MetLife's vision benefit offerings.
Company News for Sep 18, 2020
by Zacks Equity Research
Companies In The News Are: F, SRNE, JOBS, MET.
MetLife & Techstars Program to Facilitate Growth of Startups
by Zacks Equity Research
MetLife (MET) with Techstars announces the third annual class of MetLife Digital Accelerator, which offers necessary assistance for startups to grow.
Why Is MetLife (MET) Up 3.3% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MetLife (MET) Private Debt Portfolio Grows to $91.2 Billion
by Zacks Equity Research
MetLife's (MET) institutional asset management business MIM originates $6.2 billion in private placement debt in the first half of 2020.
Why Should You Stay Away From American International Now?
by Zacks Equity Research
Bleak interest rate scenario and coronavirus-triggered uncertainty are likely to drag American International's (AIG) business.
MetLife, Barnum Collaborate to Offer Financial Education
by Zacks Equity Research
MetLife (MET) partners with Barnum to offer financial education to workforces through its PlanSmart financial education programs.
Slew of Strong Earnings Pushes Insurance ETFs Higher
by Sweta Killa
A slew of strong earnings had a positive impact on the insurance ETFs, which saw smooth trading over the past week and the past month.
MetLife Banks on Cost-Control Initiatives, Cat Loss a Woe
by Zacks Equity Research
MetLife (MET) continues to benefit from improved operational excellence and solid free cash flows. However, exposure to catastrophe loss remains a concern.
MetLife (MET) Q2 Earnings Fall Shy of Estimates, Tumble Y/Y
by Zacks Equity Research
MetLife's (MET) second-quarter earnings results reflect muted revenues.
MetLife (MET) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -13.54% and -9.86%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Berkshire Hathaway (BRK.B) in Q2 Earnings?
by Zacks Equity Research
Berkshire Hathaway's (BRK.B) Q2 results are likely to reflect negative impacts of the pandemic.
MetLife (MET) to Post Earnings in Q2: What's in Store?
by Zacks Equity Research
MetLife's (MET) Q2 earnings performance is likely to have gained from higher premiums, partly offset by lower investment income.
What's in the Cards for Lincoln National's (LNC) Q2 Results?
by Zacks Equity Research
Lincoln National's (LNC) second-quarter results are likely to reflect the impact of lower interest rates, partly offset by strong expense management.
Why Earnings Season Could Be Great for MetLife (MET)
by Zacks Equity Research
MetLife (MET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Whats's in the Cards for Allstate's (ALL) Earnings in Q2?
by Zacks Equity Research
Allstate's (ALL) Q2 earnings are likely to have suffered catastrophe losses, partly offset by a rise in premiums.
Assurant (AIZ) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Assurant's (AIZ) Q2 results are likely to reflect additions of new mobile subscribers, mobile growth in both new and existing programs and lower mortality risk.
What Awaits Prudential Financial (PRU) This Earnings Season?
by Zacks Equity Research
Prudential's (PRU) Q2 are likely to reflect the re-pricing of products and shift toward lower risk and less capital-intensive products.
MetLife (MET) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
MetLife (MET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aon (AON) Gears Up to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Aon's (AON) second-quarter 2020 results are likely to have been impacted by soft revenues at most of the segments except Reinsurance Solutions, partly offset by lower expenses.